NEW YORK (GenomeWeb) – Human Longevity today announced it has signed a multi-year agreement with Genentech to conduct whole genome sequencing and analysis on tens of thousands of patient samples provided by the drug developer.

Human Longevity will sequence the genomes at 30x coverage with the Illumina HiSeq X Ten machines in its genomic sequencing center, the firm said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.